Your browser doesn't support javascript.
loading
Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice.
Ma, Zhen-Guo; Kong, Chun-Yan; Wu, Hai-Ming; Song, Peng; Zhang, Xin; Yuan, Yu-Pei; Deng, Wei; Tang, Qi-Zhu.
Afiliação
  • Ma ZG; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, RP China.
  • Kong CY; Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, RP China.
  • Wu HM; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, RP China.
  • Song P; Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, RP China.
  • Zhang X; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, RP China.
  • Yuan YP; Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, RP China.
  • Deng W; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, RP China.
  • Tang QZ; Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, RP China.
Theranostics ; 10(24): 11013-11025, 2020.
Article em En | MEDLINE | ID: mdl-33042267

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Receptor 5 Toll-Like / Cardiotoxicidade / Antibióticos Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Receptor 5 Toll-Like / Cardiotoxicidade / Antibióticos Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article